Sei Investments CO Merus N.V. Transaction History
Sei Investments CO
- $75 Billion
- Q1 2025
A detailed history of Sei Investments CO transactions in Merus N.V. stock. As of the latest transaction made, Sei Investments CO holds 11,220 shares of MRUS stock, worth $561,112. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,220Holding current value
$561,112% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRUS
# of Institutions
195Shares Held
62.2MCall Options Held
355KPut Options Held
96.5K-
Wellington Management Group LLP Boston, MA4.72MShares$236 Million0.04% of portfolio
-
Commodore Capital LP New York, NY4.47MShares$224 Million18.43% of portfolio
-
Rtw Investments, LP New York, NY4.17MShares$209 Million2.88% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.37MShares$169 Million7.27% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.17MShares$159 Million3.38% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.29B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...